Establishing and validating models integrated with hematological biomarkers and clinical characteristics for the prognosis of non-esophageal squamous cell carcinoma patients
The RSF model has better prediction power than the LASSO Cox and the TNM staging models. It has a guiding value for the choice of individualized treatment in patients with NESCC.
Authors
- Yuanye Qu
- Shulin Chen (ORCID: https://orcid.org/0000-0003-0816-2664)
- Qian Wang (ORCID: https://orcid.org/0000-0003-2319-6969)
- Jing Chen
- Xiaoyan Wen
- Yong Shen (ORCID: https://orcid.org/0000-0002-9646-164X)
- Ning Xue (ORCID: https://orcid.org/0000-0003-4748-851X)
- Qingxia Xu (ORCID: https://orcid.org/0000-0002-8925-1230)
Institutions
- Sun Yat-sen University (CN)
- Jilin University (CN)
- Zhengzhou University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Henan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1080/07853890.2025.2483985
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China